✦ LIBER ✦

Sequential doxorubicine (DOX) and docetaxel (DOC) as neoadjuvant chemotherapy in locally advanced breast cancer (LABC): A pilot study

✍ Scribed by W. Wynendaele; R. Paridaens; M.R. Christiaens; W. Van den Bogaert; A.T. van Oosterom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Locally advanced breast cancer (LABC): n

✍ W. Wynendaele; R. Paridaens; J. Wildiers; M.R. Christiaens; W. Van den Bogaert; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Neoadjuvant and Adjuvant Chemotherapy wi

✍ Vikas Malhotra; Victoria J. Dorr; Alan P. Lyss; Clay M. Anderson; Steven Westgat 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 203 KB

Docetaxel and high-dose epirubicin as ne

✍ E. Espinosa; S. Morales; P. Borrega; A. Casas; C. Madroñal; I. Machengs; J. A. I 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

434 Phase II Study of Neoadjuvant Pegyla

✍ M.K. Tuxen; S. Cold; U.B. Tange; S.B. Soendergaard; D.L. Nielsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase II study of docetaxel, capecitabin

✍ Yen-Shen Lu; Dar-Ren Chen; Ling-Min Tseng; Dah-Cherng Yeh; Shou-Tung Chen; Chia- 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Phase II study of sequential docetaxel (

✍ V. Laurence; V. Girre; J.M. Extra; V. Dieras; T. Palangie; J. Dorval; J.Y. Pierg 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 142 KB